Ufp Technologies (UFPT) Cash from Financing Activities (2010 - 2026)

Ufp Technologies (UFPT) reported Cash from Financing Activities of -$1.6 million for Q1 2026, up 84.87% on a YoY basis from -$875767.9 in Q1 2025, and up 85.12% quarter-over-quarter from -$10.9 million in Q4 2025.

Ufp Technologies (UFPT) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Ufp Technologies has reported Cash from Financing Activities for 17 years, with the latest figure at -$1.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 84.87% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$49.1 million (down 133.98% YoY), and the FY2025 full-year result was -$58.2 million, down 138.16% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$1.6 million, up from -$10.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $176.8 million in Q3 2024, with the low at -$28.9 million in Q3 2022.
  • Historically, Cash from Financing Activities has averaged $2.2 million across 5 years, with a median of -$10.7 million in 2025.
  • The largest YoY upside for Cash from Financing Activities was 3127.1% in 2022 against a maximum downside of 721350.0% in 2022.
  • Ufp Technologies' Cash from Financing Activities stood at -$20.7 million in 2022, then jumped by 45.74% to -$11.2 million in 2023, then plunged by 102.04% to -$22.7 million in 2024, then jumped by 52.09% to -$10.9 million in 2025, then surged by 85.12% to -$1.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$1.6 million (Q1 2026), -$10.9 million (Q4 2025), and -$17.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Ufp Technologies 1.85 Bn 1.83 Bn 44.36 Mn -1.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.62 Mn
Mar 31, 2026 -1.62 Mn
Dec 31, 2025 -10.88 Mn
Dec 31, 2025 -10.88 Mn
Sep 30, 2025 -17.49 Mn
Sep 30, 2025 -17.49 Mn
Jun 30, 2025 -19.08 Mn
Jun 30, 2025 -19.08 Mn
Mar 31, 2025 -10.70 Mn
Mar 31, 2025 -10.70 Mn
Dec 31, 2024 -22.72 Mn
Dec 31, 2024 -22.72 Mn
Sep 30, 2024 176.78 Mn
Sep 30, 2024 176.78 Mn
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 -2.72 Mn
Mar 31, 2024 -2.72 Mn
Dec 31, 2023 -11.24 Mn
Dec 31, 2023 -11.24 Mn